Rosemonde Mandeville

ROSEMONDE MANDEVILLE is President, Chief Executive Officer and
CSO of Biophage Pharma Inc. Dr. Mandeville is a recognized
authority in the field of applied cancer research and immunology
with special emphasis on host immunity, metastasis development
and molecular biology. Dr. Mandeville received her Medical degree
from the University of Alexandria, Egypt, and her PhD from the
University of Manitoba. She is the author of 60 publications and
160 communications in peer reviewed international journals, and
is the author of six books. She has also given over 200
conferences around the world. Dr. Mandeville serves on the Board
of Directors of Investment Quebec, Guaranty Quebec, Armand-
Frappier Foundation, Cancer Research Society and the
Bioelectromagnetic Society.